Blocking Toll-Like Receptors 7 and 9 Reduces Postinterventional Remodeling via Reduced Macrophage Activation, Foam Cell Formation, and Migration

Chlamydia pneumoniae-Induced Foam Cell Formation Requires MyD88-Dependent and -Independent Signaling and Is Reciprocally Modulated by Liver X Receptor Activation

(2014) S. Chen et al.   JOURNAL OF IMMUNOLOGY

Autoreactive B Cells Discriminate CpG-Rich and CpG-Poor DNA and This Response Is Modulated by IFN- 

(2014) M. B. Uccellini et al.   JOURNAL OF IMMUNOLOGY

Toll-Like Receptor 4 Is Involved in Human and Mouse Vein Graft Remodeling, and Local Gene Silencing Reduces Vein Graft Disease in Hypercholesterolemic APOE*3Leiden Mice

(2011) Jacco C. Karper et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Lack of Fibronectin-EDA Promotes Survival and Prevents Adverse Remodeling and Heart Function Deterioration After Myocardial Infarction

(2011) Fatih Arslan et al.   CIRCULATION RESEARCH

Unexpected protective role for Toll-like receptor 3 in the arterial wall

(2011) J. E. Cole et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Toll-like receptor 9-mediated pathway stimulates perilipin 3 (TIP47) expression and induces lipid accumulation in macrophages

(2010) Jian-Qiu Gu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice

(2010) Xinbing Han et al.   FASEB JOURNAL

Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis

(2010) Q. Huang et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

(2010) Taro Kawai et al.   NATURE IMMUNOLOGY

ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonists

(2009) Kenneth R. Feingold et al.   ATHEROSCLEROSIS

Modifications Incorporated in CpG Motifs of Oligodeoxynucleotides Lead to Antagonist Activity of Toll-like Receptors 7 and 9

(2009) Dong Yu et al.   JOURNAL OF MEDICINAL CHEMISTRY

HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses

(2009) Hideyuki Yanai et al.   NATURE

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

(2009) Cameron R Stewart et al.   NATURE IMMUNOLOGY

Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease

(2009) Kim Midwood et al.   NATURE MEDICINE

A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation

(2008) Jin-Gu Lee et al.   CELLULAR SIGNALLING

Vessel-Specific Toll-Like Receptor Profiles in Human Medium and Large Arteries

(2008) Olga Pryshchep et al.   CIRCULATION

Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma

(2008) C. Erridge et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Intranasal administration of a detoxified endotoxin vaccine protects mice against heterologous Gram-negative bacterial pneumonia

(2008) Wilbur H. Chen et al.   Innate Immunity

Oligodeoxyribonucleotide-Based Antagonists for Toll-Like Receptors 7 and 9

(2008) Daqing Wang et al.   JOURNAL OF MEDICINAL CHEMISTRY